Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 82Leukemia, Myeloid, Acute 63Leukemia, Myelomonocytic, Chronic 31Leukemia 21Myeloproliferative Disorders 15Primary Myelofibrosis 9Thrombocythemia, Essential 7Polycythemia Vera 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Blast Crisis 7Myelodysplastic-Myeloproliferative Diseases 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Recurrence 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Biphenotypic, Acute 4Anemia, Refractory, with Excess of Blasts 4Anemia, Refractory 4Leukemia, Monocytic, Acute 3Congenital Abnormalities 3Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Systemic Mastocytosis With an Associated Hematologic Neoplasm 1Preleukemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

eltrombopag 3Platelet Transfusion 2Busulfan 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2siltuximab 1oprelvekin 1fludarabine phosphate 1fludarabine 1Vitamin E 1Tranexamic Acid 1Topotecan 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1Observation 1Microarray Analysis 1Isotretinoin 1Interleukin-11 1Hematopoietic Stem Cell Transplantation 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Etoposide 1Decitabine 1DNA Methylation 1Cytogenetic Analysis 1Cytarabine 1Cyclophosphamide 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × Decitabine × Myeloid × Clear all
NCT01165996 2019-03-04

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

Case Comprehensive Cancer Center

Phase 1/2 Completed
25 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡